Published in Biomaterials on January 25, 2009
Stimuli-responsive nanocarriers for drug delivery. Nat Mater (2013) 3.52
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov (2014) 1.61
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles. Mol Pharm (2010) 1.07
Multifunctional trackable dendritic scaffolds and delivery agents. Angew Chem Int Ed Engl (2011) 1.00
Targeting polymer therapeutics to bone. Adv Drug Deliv Rev (2012) 0.98
Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation. Mol Pharm (2011) 0.96
Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest. ACS Nano (2014) 0.96
Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials (2010) 0.93
Stimulus-responsive nanopreparations for tumor targeting. Integr Biol (Camb) (2013) 0.91
Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm (2009) 0.91
Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy. J Control Release (2010) 0.91
Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci (2013) 0.90
Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications. Biomacromolecules (2010) 0.86
Oxidative stress in asthma. World Allergy Organ J (2011) 0.85
Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm (2013) 0.84
Antimicrobial activity of CdS and Ag2S quantum dots immobilized on poly(amidoamine) grafted carbon nanotubes. Colloids Surf B Biointerfaces (2012) 0.82
Enhanced bioactivity of internally functionalized cationic dendrimers with PEG cores. Biomacromolecules (2012) 0.81
Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury. J Control Release (2015) 0.80
Experimental and theoretical investigations in stimuli responsive dendrimer-based assemblies. Nanoscale (2015) 0.79
Targeted Nanotherapies for the Treatment of Surgical Diseases. Ann Surg (2016) 0.78
Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery. Bioimpacts (2011) 0.78
Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate. Int J Nanomedicine (2012) 0.78
PLA2-responsive and SPIO-loaded phospholipid micelles. Chem Commun (Camb) (2015) 0.77
Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation. J Control Release (2009) 0.77
PEG-based bioresponsive hydrogels with redox-mediated formation and degradation. J Mater Sci Mater Med (2012) 0.76
Redox and pH Responsive Poly (Amidoamine) Dendrimer-Heparin Conjugates via Disulfide Linkages for Letrozole Delivery. Biomed Res Int (2017) 0.75
Multi-Shell Hollow Nanogels with Responsive Shell Permeability. Sci Rep (2016) 0.75
Systematically probing the bottom-up synthesis of AuPAMAM conjugates for enhanced transfection efficiency. J Nanobiotechnology (2016) 0.75
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res (1986) 15.83
Glutathione. Annu Rev Biochem (1983) 15.18
Designing dendrimers for biological applications. Nat Biotechnol (2005) 4.92
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res (2005) 4.71
Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci (2003) 3.62
Dendrimers in biomedical applications--reflections on the field. Adv Drug Deliv Rev (2005) 3.39
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev (2003) 3.25
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release (2000) 3.07
Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med (1999) 2.94
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today (2001) 2.71
Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev (2005) 2.56
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A (2006) 2.55
Intravenous administration of oral N-acetylcysteine. Crit Care Med (1998) 2.46
Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res (1984) 1.98
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev (2005) 1.97
The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials (2008) 1.74
Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs (1999) 1.67
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem (2002) 1.46
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm (2003) 1.36
Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 1.36
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J (2004) 1.30
Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res (2004) 1.29
Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res (2007) 1.25
Synthetic peptides in the form of dendrimers become resistant to protease activity. J Biol Chem (2003) 1.20
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem (2006) 1.19
Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med (2001) 1.17
Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases. Free Radic Biol Med (2008) 1.16
Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjug Chem (2008) 1.13
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials (2005) 1.11
Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem (2005) 1.09
Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol (2007) 1.08
Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid. J Control Release (2003) 1.00
Evaluation of multivalent dendrimers based on melamine: kinetics of thiol-disulfide exchange depends on the structure of the dendrimer. J Am Chem Soc (2003) 0.98
Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species. Biochem Biophys Res Commun (2003) 0.95
Synthesis, characterization and stability of dendrimer prodrugs. Int J Pharm (2005) 0.95
Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol (Noisy-le-grand) (2004) 0.91
In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release (1999) 0.90
Synthesis and biological evaluation of disulfide-linked HPMA copolymer-mesochlorin e6 conjugates. Macromol Biosci (2008) 0.89
Kinetic analysis of covalent binding between N-acetyl-L-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro. Pharm Res (2002) 0.83
The Amber biomolecular simulation programs. J Comput Chem (2005) 28.84
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol (2005) 5.27
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell (2008) 4.90
Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release (2006) 3.85
The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev (2003) 3.53
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43
Hedgehog-regulated Costal2-kinase complexes control phosphorylation and proteolytic processing of Cubitus interruptus. Dev Cell (2005) 2.50
Hedgehog signalling activity of Smoothened requires phosphorylation by protein kinase A and casein kinase I. Nature (2004) 2.39
Genome sequencing and comparative transcriptomics of the model entomopathogenic fungi Metarhizium anisopliae and M. acridum. PLoS Genet (2011) 2.35
Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus. Nature (2002) 2.26
Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proc Natl Acad Sci U S A (2010) 2.16
A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. Dev Cell (2006) 2.13
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther (2008) 2.07
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther (2011) 2.04
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today (2010) 2.03
Controlling the Kondo effect of an adsorbed magnetic ion through its chemical bonding. Science (2005) 1.98
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol (2010) 1.86
Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release (2007) 1.79
The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials (2008) 1.74
Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci (2007) 1.74
Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther (2008) 1.65
Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J (2011) 1.63
Phosphorylation by double-time/CKIepsilon and CKIalpha targets cubitus interruptus for Slimb/beta-TRCP-mediated proteolytic processing. Dev Cell (2005) 1.62
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med (2010) 1.62
Microporous and photoluminescent chalcogenide zeolite analogs. Science (2002) 1.61
Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58
Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum Gene Ther (2002) 1.56
Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther (2010) 1.56
Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 1.51
Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase. Proc Natl Acad Sci U S A (2009) 1.47
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin Cancer Res (2013) 1.47
Fine-mapping gene-by-diet interactions on chromosome 13 in a LG/J x SM/J murine model of obesity. Diabetes (2005) 1.47
Regulation of TopBP1 oligomerization by Akt/PKB for cell survival. EMBO J (2006) 1.45
Retracted Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis. J Ovarian Res (2013) 1.42
Atomic structure, energetics, and dynamics of topological solitons in indium chains on Si(111) surfaces. Phys Rev Lett (2011) 1.42
Structural Survey of Zinc Containing Proteins and the Development of the Zinc AMBER Force Field (ZAFF). J Chem Theory Comput (2010) 1.37
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm (2003) 1.36
Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 1.36
Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res (2005) 1.32
Formal Estimation of Errors in Computed Absolute Interaction Energies of Protein-ligand Complexes. J Chem Theory Comput (2011) 1.32
Genomic imprinting effects on adult body composition in mice. Proc Natl Acad Sci U S A (2008) 1.31
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One (2012) 1.29
A method of calculating the second dimension retention index in comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. J Chromatogr A (2011) 1.28
Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer. Mol Cell Biol (2009) 1.28
Prediction of protein-protein interactions from amino acid sequences with ensemble extreme learning machines and principal component analysis. BMC Bioinformatics (2013) 1.26
Identification of quantitative trait loci affecting murine long bone length in a two-generation intercross of LG/J and SM/J Mice. J Bone Miner Res (2008) 1.26
Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol (2012) 1.26
The immediate environment during postnatal development has long-term impact on gut community structure in pigs. ISME J (2008) 1.25
Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation (2004) 1.25
An optimal peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using mixture similarity measure. Bioinformatics (2011) 1.22
Genetic architecture of adiposity and organ weight using combined generation QTL analysis. Obesity (Silver Spring) (2008) 1.20
Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines. Bioconjug Chem (2006) 1.19
MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics. Anal Chem (2011) 1.19
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Clin Cancer Res (2008) 1.19
Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology (2008) 1.19
Dietary anthocyanin-rich tart cherry extract inhibits intestinal tumorigenesis in APC(Min) mice fed suboptimal levels of sulindac. J Agric Food Chem (2006) 1.18
Pleiotropic patterns of quantitative trait loci for 70 murine skeletal traits. Genetics (2008) 1.18
Monitoring nitrogen deposition in typical forest ecosystems along a large transect in China. Environ Monit Assess (2012) 1.18
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis (2012) 1.17
G protein-coupled receptor kinase 2 promotes high-level Hedgehog signaling by regulating the active state of Smo through kinase-dependent and kinase-independent mechanisms in Drosophila. Genes Dev (2010) 1.17
Salmonella enterica serovar Senftenberg human clinical isolates lacking SPI-1. J Clin Microbiol (2008) 1.17
Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy (2008) 1.16
Interface-confined ferrous centers for catalytic oxidation. Science (2010) 1.15
Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjug Chem (2008) 1.13
Hepatoprotective and antioxidant effects of licorice extract against CCl₄-induced oxidative damage in rats. Int J Mol Sci (2011) 1.12
Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials (2005) 1.11
iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data. J Chromatogr A (2011) 1.11
Anterior debridement and reconstruction via thoracoscopy-assisted mini-open approach for the treatment of thoracic spinal tuberculosis: minimum 5-year follow-up. Eur Spine J (2011) 1.11
Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release (2004) 1.10
Surgical treatment of cervical kyphosis. Eur Spine J (2010) 1.10
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum Mol Genet (2011) 1.10
The energy computation paradox and ab initio protein folding. PLoS One (2011) 1.10
Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration. Biomaterials (2011) 1.10
Hedgehog-regulated ubiquitination controls smoothened trafficking and cell surface expression in Drosophila. PLoS Biol (2012) 1.09
Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine (2013) 1.09
Fish MITA serves as a mediator for distinct fish IFN gene activation dependent on IRF3 or IRF7. J Immunol (2011) 1.09
Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem (2005) 1.09
The role of quantum mechanics in structure-based drug design. Drug Discov Today (2007) 1.09
Individual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma. Am J Physiol Regul Integr Comp Physiol (2009) 1.08
Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet (2003) 1.08
Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am J Physiol Heart Circ Physiol (2008) 1.07
Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy. Hum Gene Ther (2008) 1.07
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study. Ann Rheum Dis (2011) 1.06
Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci (2008) 1.06
Characteristics and living patterns of marine myxobacterial isolates. Appl Environ Microbiol (2005) 1.05
NGS catalog: A database of next generation sequencing studies in humans. Hum Mutat (2012) 1.05
Replication of long-bone length QTL in the F9-F10 LG,SM advanced intercross. Mamm Genome (2009) 1.05
Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine (Lond) (2010) 1.04
Regulation of wingless signaling by the CKI family in Drosophila limb development. Dev Biol (2006) 1.04
Enhanced surface plasmon resonance on a smooth silver film with a seed growth layer. ACS Nano (2010) 1.03